Latest Vaccines news
Physician’s Briefing Weekly Coronavirus Roundup
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
BNT162b2 Vaccine Effectiveness 92 Percent for Teens Ages 12 to 17
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Adverse Events Rare After BNT162b2 Vaccine in 5- to 11-Year-Olds
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA May Allow Pfizer Boosters for 12- to 15-Year-Olds by Monday
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
EHR-Enabled QI Intervention Improves Chlamydia, Gonorrhea Screening in Teens .jpg)
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder 
Nutritional Deficiencies Seen in Youth Taking GLP-1 Receptor Agonists 
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia Related Articles
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease 
Trends Reported in Vaccination Coverage for Adolescents for 2025 
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer Monthly Specialist Briefings
Stay Connected
